Related references
Note: Only part of the references are listed.A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
Danielle Coppola et al.
BMC PSYCHIATRY (2012)
Nocturnal enuresis with antipsychotic medication
Thomas R. E. Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Paliperidone Palmitate for Schizophrenia
Abraham M. Nussbaum et al.
SCHIZOPHRENIA BULLETIN (2012)
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Cynthia A. Bossie et al.
BMC PSYCHIATRY (2011)
Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study
Mira Harrison-Woolrych et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
S. Gopal et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
Gahan Pandina et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
Michelle Kramer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
Gahan J. Pandina et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
Henry A. Nasrallah et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
David Hough et al.
SCHIZOPHRENIA RESEARCH (2010)
Risperidone-related reversal of primary enuresis: An unusual case report
D. N. Mendhekar et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Once-monthly paliperidone injection for the treatment of schizophrenia
Delia Bishara
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2010)
Second-generation antipsychotic long-acting injections: systematic review
W. Wolfgang Fleischhacker
BRITISH JOURNAL OF PSYCHIATRY (2009)
Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic
Mahesh N. Samtani et al.
CLINICAL PHARMACOKINETICS (2009)
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release
Luca Pani et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Urinary incontinence associated with amisulpride
Dattatreya Mendhekar et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Paliperidone for schizophrenia
Christian Dolder et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Three cases of risperidone-induced enuresis
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2006)